Clinical trials
Chronic Kidney Insufficiency clinical trials
Below are recruiting chronic kidney insufficiency clinical trials, each written for real people, not researchers. We’re tracking 54 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07025629RecruitingPhase 3
Dapagliflozin after ICU discharge for heart and kidney health
This study tests if the drug dapagliflozin (a medicine that helps protect the heart and kidneys) can improve recovery in patients who needed a breathing machine or blood pressure support in the ICU. If you qualify, you would take the drug after leaving the ICU to see if it lowers the risk of heart or kidney problems.
ParisAges 18 years+ - NCT07021157RecruitingPhase 1
First-in-human study of SK-08 in healthy volunteers
This trial tests a new drug called SK-08 in healthy volunteers to see if it's safe and how the body processes it. It helps doctors find the right dose for future studies of this potential medicine.
Hangzhou, ZhejiangAges 18–45 - NCT04759274Recruiting
Personalized water pill dosing support for kidney and fluid overload
This trial tests a decision-support tool to help your care team safely adjust water pills (“diuretics”) when you have kidney disease and fluid buildup. It may help reduce swelling by guiding dosing using your home weight and blood pressure.
Dallas, TexasAges 18 years+ - NCT05326399Recruiting
Kidney biopsies after liver transplant for new kidney problems
This trial studies kidney biopsies in people who had a liver transplant and then developed new signs of kidney damage. The goal is to better understand what’s causing the problem and how to guide next steps.
ShanghaiAges 18–75 - NCT06418282Recruiting
Portable compression device for leg swelling
This study tests a new portable device that wraps around your leg to gently squeeze and reduce swelling from lymphedema or vein problems. It aims to see if at-home use can improve symptoms and lower healthcare costs compared to standard care.
New York, New YorkAges 18–100 - NCT04671771Recruiting
Testing a new graft for hemodialysis access in kidney failure
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
Phoenix, ArizonaAges 18–90
Hear when a new Chronic Kidney Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for chronic kidney insufficiency?
- Yes. Clin2 currently lists 54 recruiting chronic kidney insufficiency studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a chronic kidney insufficiency trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a chronic kidney insufficiency trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.